Estrogen Receptors &agr; and &bgr; Mediate Contribution of Bone Marrow–Derived Endothelial Progenitor Cells to Functional Recovery After Myocardial Infarction

Background— Estradiol (E2) modulates the kinetics of circulating endothelial progenitor cells (EPCs) and favorably affects neovascularization after ischemic injury. However, the roles of estrogen receptors &agr; (ER&agr;) and &bgr; (ER&bgr;) in EPC biology are largely unknown. Methods and Results— In response to E2, migration, tube formation, adhesion, and estrogen-responsive element–dependent gene transcription activities were severely impaired in EPCs obtained from ER&agr;-knockout mice (ER&agr;KO) and moderately impaired in ER&bgr;KO EPCs. The number of ER&agr;&Kgr;&Ogr; EPCs (42.4±1.5; P<0.001) and ER&bgr;KO EPCs (55.4±1.8; P= 0.03) incorporated into the ischemic border zone was reduced as compared with wild-type (WT) EPCs (72.5±1.3). In bone marrow transplantation (BMT) models, the number of mobilized endogenous EPCs in E2-treated mice was significantly reduced in ER&agr;KO BMT (WT mice transplanted with ER&agr;KO bone marrow) (2.03±0.18%; P= 0.004 versus WT BMT) and ER&bgr;KO BMT (2.62±0.07%; P= 0.02 versus WT) compared with WT BMT (2.87±0.13%) (WT to WT BMT as control) mice. Capillary density at the border zone of ischemic myocardium also was significantly reduced in ER&agr;KO BMT and ER&bgr;KO BMT compared with WT mice (WT BMT, 1718±75/mm2; ER&agr;KO BMT, 1107±48/mm2; ER&bgr;KO BMT, 1567±50/mm2). ER&agr; mRNA was expressed more abundantly on EPCs compared with ER&bgr;. Moreover, vascular endothelial growth factor was significantly downregulated on ER&agr;KO EPCs compared with WT EPCs both in vitro and in vivo. Conclusions— Both ER&agr; and ER&bgr; contribute to E2-mediated EPC activation and tissue incorporation and to preservation of cardiac function after myocardial infarction. ER&agr; plays a more prominent role in this process. Moreover, ER&agr; contributes to upregulation of vascular endothelial growth factor, revealing possible mechanisms of an effect of E2 on EPC biology. Finally, these data provide additional evidence of the importance of bone marrow–derived EPC phenotype in ischemic tissue repair.

[1]  H. Masuda,et al.  Estradiol Enhances Recovery After Myocardial Infarction by Augmenting Incorporation of Bone Marrow–Derived Endothelial Progenitor Cells Into Sites of Ischemia-Induced Neovascularization via Endothelial Nitric Oxide Synthase–Mediated Activation of Matrix Metalloproteinase-9 , 2006, Circulation.

[2]  T. Asahara,et al.  Dose-Dependent Contribution of CD34-Positive Cell Transplantation to Concurrent Vasculogenesis and Cardiomyogenesis for Functional Regenerative Recovery After Myocardial Infarction , 2006, Circulation.

[3]  E. Chavakis,et al.  Differentiation of circulating endothelial progenitor cells to a cardiomyogenic phenotype depends on E‐cadherin , 2005, FEBS letters.

[4]  T. Asahara,et al.  Endothelial Progenitor Cells Are Rapidly Recruited to Myocardium and Mediate Protective Effect of Ischemic Preconditioning via “Imported” Nitric Oxide Synthase Activity , 2005, Circulation.

[5]  Geoffrey C Gurtner,et al.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.

[6]  J. Isner,et al.  Estrogen-Mediated, Endothelial Nitric Oxide Synthase–Dependent Mobilization of Bone Marrow–Derived Endothelial Progenitor Cells Contributes to Reendothelialization After Arterial Injury , 2003, Circulation.

[7]  D. Torella,et al.  Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.

[8]  U. Dirnagl,et al.  Estrogen Increases Bone Marrow‐Derived Endothelial Progenitor Cell Production and Diminishes Neointima Formation , 2003, Circulation.

[9]  G. Figtree,et al.  Truncated Estrogen Receptor &agr; 46-kDa Isoform in Human Endothelial Cells: Relationship to Acute Activation of Nitric Oxide Synthase , 2003, Circulation.

[10]  P. Shaul,et al.  Estrogen Causes Dynamic Alterations in Endothelial Estrogen Receptor Expression , 2002, Circulation research.

[11]  H. Kleinman,et al.  Tissue and Serum Angiogenic Activity Is Associated With Low Prevalence of Ischemic Complications in Patients With Giant-Cell Arteritis , 2002, Circulation.

[12]  J. Milanini,et al.  Transcriptional Regulation of Vascular Endothelial Growth Factor by Estradiol and Tamoxifen in Breast Cancer Cells: A Complex Interplay between Estrogen Receptors α and β , 2002 .

[13]  J. Isner,et al.  Constitutive Human Telomerase Reverse Transcriptase Expression Enhances Regenerative Properties of Endothelial Progenitor Cells , 2002, Circulation.

[14]  I. Spyridopoulos,et al.  Functionally Novel Tumor Necrosis Factor-&agr;–Modulated CHR-Binding Protein Mediates Cyclin A Transcriptional Repression in Vascular Endothelial Cells , 2002, Circulation research.

[15]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[16]  P. Chambon,et al.  Estrogen Receptor-&agr; Mediates the Protective Effects of Estrogen Against Vascular Injury , 2002, Circulation research.

[17]  A. Go,et al.  Hormone Therapy and In-Hospital Survival After Myocardial Infarction in Postmenopausal Women , 2001, Circulation.

[18]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[19]  D. Kremastinos,et al.  Intramuscular administration of estrogen may promote angiogenesis and perfusion in a rabbit model of chronic limb ischemia. , 2001, Cardiovascular research.

[20]  P. Chambon,et al.  Estradiol Accelerates Reendothelialization in Mouse Carotid Artery Through Estrogen Receptor-&agr; but Not Estrogen Receptor-&bgr; , 2001, Circulation.

[21]  P. Chambon,et al.  Estradiol Accelerates Reendothelialization in Mouse Carotid Artery Through Estrogen Receptor-α but Not Estrogen Receptor-β , 2001 .

[22]  M. Perrot-Applanat,et al.  Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia. , 2000, American journal of physiology. Heart and circulatory physiology.

[23]  P. Chambon,et al.  Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. , 2000, Development.

[24]  M. Mueller,et al.  Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Stancel,et al.  Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. , 2000, Cancer research.

[26]  J. Gustafsson,et al.  Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Ruixiang Li,et al.  Tumor gangliosides inhibit the tumor-specific immune response. , 1999, Journal of immunology.

[28]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[29]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[30]  T. Tamaya,et al.  Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells. , 1999, Cancer letters.

[31]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[32]  M. Karkkainen,et al.  Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells , 1999, Molecular and Cellular Endocrinology.

[33]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[34]  C. Grohé,et al.  Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. , 1998, The Journal of endocrinology.

[35]  R. Karas,et al.  Cardiac myocytes and fibroblasts contain functional estrogen receptors 1 , 1997, FEBS letters.

[36]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[37]  A. Brodie,et al.  Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. , 1996, Endocrinology.

[38]  W. Frederiks,et al.  Nitric oxide synthase activity. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[39]  K. Korach,et al.  Disruption of estrogen receptor gene prevents 17 beta estradiol-induced angiogenesis in transgenic mice. , 1996, Endocrinology.

[40]  S. Hubchak,et al.  Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. , 1996, Circulation.

[41]  D. Vaughan,et al.  Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. , 1996, Circulation.

[42]  Y. Meng,et al.  Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. , 1996, The Journal of clinical endocrinology and metabolism.

[43]  H. Schnaper,et al.  Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. , 1995, Circulation.

[44]  N. Weidner,et al.  Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. , 1994, The American journal of pathology.

[45]  Michael S. Pepper,et al.  The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth , 1994, Nature.

[46]  R Bicknell,et al.  Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. , 1993, Cancer research.

[47]  R. Koos,et al.  Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. , 1993, Endocrinology.

[48]  D. Charnock-Jones,et al.  Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. , 1993, Biology of reproduction.

[49]  G. Neufeld,et al.  Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. , 1993, The Journal of clinical investigation.

[50]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[51]  M. Perrot-Applanat,et al.  Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation , 2004, Angiogenesis.

[52]  J. Milanini,et al.  Transcriptional Regulation of Vascular Endothelial Growth Factor by Estradiol and Tamoxifen in Breast Cancer Cells : A Complex Interplay between Estrogen Receptors and 1 , 2002 .

[53]  R. Karas,et al.  Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. , 1997, Nature medicine.